Hemodynamic effects of glucagon in porta
β
Guillermo Silva; Miquel Navasa; Dr. Jaime Bosch; Jaime Chesta; M. Pilar Pizcueta
π
Article
π
1990
π
John Wiley and Sons
π
English
β 684 KB
It has been suggested that glucagon contributes to the pathogenesis of portal hypertension by increasing portal blood flow. This study examined this issue by assessing the hemodynamic effects of a pharmacological dose of glucagon (1 mg, intravenously) in patients with cirrhosis and portal hypertensi